Scaffold RNA Dynamic Control of Protein Colocalization

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current synthetic metabolons lack dynamic control over metabolic flux distribution after assembly, lacking feedback loops to prevent substrate depletion or product accumulation, which limits their efficiency in metabolic engineering applications.

Innovation Solution

The use of scaffold RNA molecules with specific binding motifs, hybridization sequences, and toehold sequences allows for the dynamic colocalization and separation of heterologous proteins through toehold-mediated strand displacement (TMSD), enabling controlled metabolic flux management.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If scaffold RNA molecules are used to assemble synthetic metabolons, then protein colocalization and metabolic flux control are improved, but dynamic control capability and feedback mechanisms are lost

Engineering Contradiction:
Improvemetabolic flux controlVSAvoiddynamic control capability
Core Design Contradiction:
ProductivityVSAdaptability or versatility

Solution Approach 1:

The patent applies dynamics by designing scaffold RNA molecules with toehold sequences that enable conditional assembly and disassembly of synthetic metabolons. The scaffold RNA can dynamically respond to cellular conditions through toehold-mediated strand displacement, allowing the metabolon structure to transition between assembled and disassembled states based on metabolic needs, thus providing both structural organization and dynamic adaptability

Inventive Principle:
Principle #15Dynamics

Solution Approach 2:

The patent implements feedback mechanisms by incorporating sensor domains into the scaffold RNA design that can detect metabolic intermediates or end-products. When specific metabolic conditions are detected, the sensor domains trigger conformational changes or recruit nucleases that cleave the scaffold RNA, thereby disassembling the metabolon and providing feedback control over metabolic flux to prevent substrate depletion or product accumulation

Inventive Principle:
Principle #23Feedback

2Ease of manufacture

If enzymes are introduced through genetic vectors, then metabolic pathway introduction is achieved, but optimization of turnover and expression rates is required

Engineering Contradiction:
Improvemetabolic pathway introductionVSAvoidexpression optimization
Core Design Contradiction:
Ease of manufactureVSDevice complexity

Solution Approach 1:

The patent uses scaffold RNA molecules as intermediaries to organize enzymes into metabolons, which facilitates substrate channeling and improves metabolic flux without requiring extensive optimization of individual enzyme expression levels. The scaffold RNA acts as a mediator that brings enzymes into close proximity, allowing the system to achieve high productivity even with moderate expression levels of individual pathway enzymes

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent segments the metabolic pathway into modular enzyme complexes organized on scaffold RNA molecules. Each enzyme can be independently introduced via genetic vectors and then organized into functional metabolons through the scaffold RNA, allowing for simplified introduction of the complete pathway while maintaining the ability to optimize individual enzyme components separately

Inventive Principle:
Principle #1Segmentation

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables dynamic assembly and disassembly of protein scaffolds, allowing for precise control of metabolic flux and improving product yields by preventing substrate depletion and product accumulation, thus enhancing metabolic engineering efficiency.

Implementation Method 1

expressing the first heterologous protein and a first scaffold RNA molecule in the cell, wherein the first scaffold RNA molecule comprises a first binding motif, a hybridization sequence and a toehold sequence, the first heterologous protein is bound to the first binding motif

Methodology Applied
Scientific EffectRNA-protein binding:

Implementation Method 2

the first hybridization sequence is bound to a first sequence complementary with the hybridization sequence

Methodology Applied
Scientific EffectNucleic acid hybridization:

Implementation Method 3

the first scaffold RNA molecule comprises a first binding motif, a hybridization sequence and a toehold sequence... the trigger RNA molecule comprises a first trigger sequence complementary with the toehold sequence... whereby the first trigger sequence complementary with the toehold sequence is bound to the toehold sequence

Methodology Applied
Scientific EffectToehold-mediated strand displacement:

Data Source

PatentUS11530278B2Dynamic control of colocalization of proteins
Publication Date: 2022.12.20 UNIVERSITY OF DELAWARE
  • US11530278B2 patent drawing
  • US11530278B2 patent drawing
  • US11530278B2 patent drawing

AI summary

The present invention provides a method for controlling colocalization of two or more proteins in a cell. The method comprises expressing the proteins, scaffold RNA molecules having binding motifs for the proteins, and a trigger RNA molecule in the cell. In the presence of the trigger RNA molecule, a scaffold may be assembled (ON) by the scaffold RNA molecules via hybridization such that the proteins may be colocalized; or disassembled (OFF) such that the proteins may be separated and not colocalized. The proteins may provide a biological activity when colocalized or not colocalized.